Radiomics in breast MRI: Current progress toward clinical application in the era of artificial intelligence
H Satake, S Ishigaki, R Ito, S Naganawa - La radiologia medica, 2022 - Springer
Breast magnetic resonance imaging (MRI) is the most sensitive imaging modality for breast
cancer diagnosis and is widely used clinically. Dynamic contrast-enhanced MRI is the basis …
cancer diagnosis and is widely used clinically. Dynamic contrast-enhanced MRI is the basis …
[HTML][HTML] How radiomics can improve breast cancer diagnosis and treatment
F Pesapane, P De Marco, A Rapino… - Journal of Clinical …, 2023 - mdpi.com
Recent technological advances in the field of artificial intelligence hold promise in
addressing medical challenges in breast cancer care, such as early diagnosis, cancer …
addressing medical challenges in breast cancer care, such as early diagnosis, cancer …
[HTML][HTML] Radiomic analysis in contrast-enhanced spectral mammography for predicting breast cancer histological outcome
Contrast-Enhanced Spectral Mammography (CESM) is a recently introduced
mammographic method with characteristics particularly suitable for breast cancer radiomic …
mammographic method with characteristics particularly suitable for breast cancer radiomic …
[HTML][HTML] Recent radiomics advancements in breast cancer: lessons and pitfalls for the next future
Radiomics is an emerging translational field of medicine based on the extraction of high-
dimensional data from radiological images, with the purpose to reach reliable models to be …
dimensional data from radiological images, with the purpose to reach reliable models to be …
Benchmarking feature selection methods in radiomics
A Demircioğlu - Investigative radiology, 2022 - journals.lww.com
Objectives A critical problem in radiomic studies is the high dimensionality of the datasets,
which stems from small sample sizes and many generic features extracted from the volume …
which stems from small sample sizes and many generic features extracted from the volume …
[HTML][HTML] Multiparametric Integrated 18F-FDG PET/MRI-Based Radiomics for Breast Cancer Phenotyping and Tumor Decoding
L Umutlu, J Kirchner, NM Bruckmann, J Morawitz… - Cancers, 2021 - mdpi.com
Simple Summary Breast cancer is considered the leading cancer type and main cause of
cancer death in women. In this study, we assess simultaneous 18F-FDG PET/MRI of the …
cancer death in women. In this study, we assess simultaneous 18F-FDG PET/MRI of the …
MRI-based radiomics methods for predicting Ki-67 expression in breast cancer: A systematic review and meta-analysis
Rationale and Objectives The purpose of this systematic review and meta-analysis was to
assess the quality and diagnostic accuracy of MRI-based radiomics for predicting Ki-67 …
assess the quality and diagnostic accuracy of MRI-based radiomics for predicting Ki-67 …
[HTML][HTML] Artificial intelligence-enhanced breast MRI: applications in breast cancer primary treatment response assessment and prediction
RL Gullo, E Marcus, J Huayanay… - Investigative …, 2024 - journals.lww.com
Primary systemic therapy (PST) is the treatment of choice in patients with locally advanced
breast cancer and is nowadays also often used in patients with early-stage breast cancer …
breast cancer and is nowadays also often used in patients with early-stage breast cancer …
Radiomics and artificial intelligence analysis by T2-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging to predict Breast Cancer …
Objective The objective of the study was to evaluate the accuracy of radiomics features
obtained by MR images to predict Breast Cancer Histological Outcome. Methods A total of …
obtained by MR images to predict Breast Cancer Histological Outcome. Methods A total of …
[HTML][HTML] Multiparametric 18F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
L Umutlu, J Kirchner, NM Bruckmann, J Morawitz… - Cancers, 2022 - mdpi.com
Simple Summary In breast cancer, the leading cancer type and the main cause of cancer
death in women, achieving pathological complete response after neoadjuvant …
death in women, achieving pathological complete response after neoadjuvant …